Cardiology
Arrhythmias
More in Arrhythmias
Phase IIb trial strongly favors safety of novel agent over DOAC, but stroke impact still unclear
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Health news and commentary gathered by 鶹ý staff
Device was recently approved for drug-refractory paroxysmal atrial fibrillation
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing
Signal largely driven by newly emerging arrhythmias
Recent developments of interest in cardiovascular medicine
Two cohort studies didn't find significantly greater risk than other drugs in epilepsy
Stress, CVD, pain symptoms highly prevalent in those evaluated in New York City
